Skip to main content
Psychiatry
ALL Specialities
ALL Specialities
/
Psychiatry
COVID-19 Updates
News
From the Journals
FDA/CDC
Guidelines
Feature
Latest News
News by Conference
News from the FDA/CDC
Perspectives
Commentary
Curbside Consult
Families in Psychiatry
For Residents
From the Editor
Interview
Mental Health Consult
Shrink Rap News
Techiatry
Weighty Issues
Supplements
Reviews
Cases That Test Your Skills
Clinical Neuroscience
Evidence-Based Reviews
Med/Psych Update
Out of the Pipeline
Pearls
Savvy Psychopharmacology
CME
CME Supplements
Medical Education Library
Diseases and Conditions
Addiction Medicine
ADHD
Alzheimer's & Cognition
Anxiety Disorders
Bipolar Disorder
Depression
Eating Disorders
Movement Disorders
Personality Disorders
PTSD
Schizophrenia & Other Psychotic Disorders
Sleep Medicine
Somatic Disorders
Multimedia
Podcasts
Video
Resource Center
Lifestyle
News
Vital Signs: Antipsychotics Were the Top Therapeutic Class in 2009
Publish date:
August 1, 2010
PDF Download
70298_fx1.sml
Vitals
Source Elsevier Global Medical News
Recommended Reading
Psychosis Could Be Linked to Blood-Brain Barrier Disruption
MDedge Psychiatry
Antipsychotics and Kids: Data Mostly Reassuring
MDedge Psychiatry
Early Marijuana Use Tied to Adult Psychosis Risk
MDedge Psychiatry
For Children on Antipsychotics, Metabolic Changes Occur Rapidly
MDedge Psychiatry
Could diet cause psychosis?
MDedge Psychiatry
Weighing clozapine’s risks
MDedge Psychiatry
Paliperidone palmitate: Once-monthly treatment option for schizophrenia
MDedge Psychiatry
A REMINDER for assessing psychosis
MDedge Psychiatry
Typicals vs atypicals
MDedge Psychiatry
The woman who saw the light
MDedge Psychiatry
Schizophrenia & Other Psychotic Disorders
All Specialties
